Useful roundup of the various legal 'protocol's being used to sort out compliance with the new regs. Update on ISDA Protocols | Dodd-Frank and the Law.
US DFA CFTC Addressing Overlaps Between EMIR and CFTC Derivatives Regulation, white paper via AIMA below. AIMA - Document Summary.
If you're on the buy-side the survey below from Risk Magazine gives some interesting insights into why firms choose a particular Clearing Broker or FCM, and who's leading the race to scoop up Client Clearing business.
JW explains why there is plenty of room for innovation between Listed and OTC markets in the new regulatory environment.
via John Wilson on Vimeo.
One of the major projects currently going on for all industry participants is Trade Reporting following EMIR mandate.
LCH SwapClear have implemented a change in their Initial Margin methodology and this article will discuss three elements that constitute the change:
John Philpott commenting on the previous EMIR 5 month delay story points out:
SWP points out the worst of Dodd Frank (in his opinion), the Made Available to Trade rule (MAT). Have a read of his post, then think about some scenarios this could cause:
On the ESMA website a new timeline popped into view a few days ago (Source: http://www.esma.europa.eu/page/European-Market-Infrast
In the same vein as delaying the June 10th deadline, follow the link to an article and PDF from Cleary Gottlieb on what exactly needs to be done for June 10th.
TSR call for a delay to the June 10th deadline, apparently due to the unprecedented number of enquires on what sorts of firms, and which products should be cleared.
An observation on the volumes in the swap market from our very own contributor Amir at ClarusFT. Have you entered the competition for an iPad yet, see the home page or ClarusFT.com.
An article published today in Risk Magazine states that Eurex are in the process of consulting market participants around th
A great piece by Nick Fry on DerivSource regrading the changes that Industry will go through in its efforts to comply with regulation requirements.
Spotted by Sapient here, the Canadian Securities Administrator has published a paper setting out their proposals for the regulation of OTC derivatives in Canada.